Gentibio

• Payam Zarin

  Associate director

Sources: reporter.nih.gov

• National Institute of Neurological Disorders and Stroke

  R44, Development of Tissue Engineered Tregs as a Treatment for Acute Ischemic Stroke, R44NS145848, US$1.2m, 2025–2027, 8 Jul 2026

Sources: reporter.nih.gov

• Cardiovascular safety of orforglipron versus insulin glargine in adults with type 2 diabetes at increased cardiovascular risk (ACHIEVE-4): a phase 3, event-driven, randomised, open-label, non-inferiority, active comparator trial

  Fees or honoraria, Grants or research support, 30 Sept 2026

• Evaluation of clinical relevance of weight nadirs and weight regain during 3 years of treatment with tirzepatide in participants with obesity or overweight and prediabetes

  Fees or honoraria, Grants or research support, 18 Sept 2026

• Effect of semaglutide on kidney outcomes in the SELECT, FLOW, and SOUL trials: a prespecified pooled analysis

  Employment, Grants or research support, 7 Aug 2026

• Weight Loss Intervention Promoting an Adapted Mediterranean-Style Dietary Pattern: The DELISH Randomized Clinical Trial

  Employment, 3 Aug 2026

Sources: pubmed.ncbi.nlm.nih.gov, europepmc.org